Lenvatinib-d4 (E7080-d4) is the deuterium labeled Lenvatinib. Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibitsVEGFR1-3,FGFR1-4,PDGFR,KIT, andRET, shows potent antitumor activities^[1][2].

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1].

430.88

Solid

C₂₁H₁₅D₄ClN₄O₄

乐伐替尼 d4

Room temperature in continental US; may vary elsewhere.